CIS ONCOLOGY LIMITED

Legal registered address
5 Argosy Court Scimitar Way Whitley Business Park Coventry West Midlands CV3 4GA Copied!
Check director history across all UK companiesAI Assistant tracks all appointments, resignations, and dissolved companies instantly.
Learn More →

Company number
02431816 Copied!
Company status
Active
Company type
Private Limited Company
Accounts category
Small
Incorporated on
12 October 1989
Accounts

Latest annual accounts were to 31 March 2024

Next annual accounts are due by 31 December 2025

Company financial year end is on 31 March 2026

Confirmation statement

Latest confirmation statement statement dated 17 October 2023

Next statement due by 31 October 2024

View original and historic source data
Nature of business (SIC)

70229 - Management consultancy activities other than financial management

Previous company names

NameDate previous name changed
ACCOUNTING FOR CHANGE LIMITED2 March 1998
CLINISIS LIMITED24 September 2004
CLINISYS ONCOLOGY LIMITED27 September 2007

Latest company documents
DateDescription
28/01/2528 January 2025

View Document

28/01/2528 January 2025 Statement of capital on 2025-01-28

View Document

28/01/2528 January 2025

View Document

28/01/2528 January 2025 Resolutions

View Document

12/11/2412 November 2024 Confirmation statement made on 2024-10-17 with updates

View Document

View all company documents
AI-Powered Analysis for CIS ONCOLOGY LIMITED

Get instant insights with Claude AI. Ask questions like:

  • "Is CIS ONCOLOGY LIMITED financially stable?"
  • "What are the key risks for lending to this company?"
  • "Show me the director history and red flags"
Set Up AI Assistant

Takes 60 seconds • Works with Claude.ai


More Company Information

AI Company Analysis

Ask Claude AI about CIS ONCOLOGY LIMITED:


Start Free Setup →

No downloads • 60 second setup


Follow Company
  • Receive an alert email on changes to financial status
  • Early indications of liquidity problems
  • Warns when company reporting is overdue
  • Free service, no spam emails
  • Follow this company